12-Month Lobbying Summary - Organization

Organon Canada Inc. / Organon Canada inc. / Dominic Bégin, President & Managing Director

Registration Summary

Currently active - Last Updated: 2026-06-01

Who is lobbying?

Organon Canada Inc. / Organon Canada inc. (Address & business activities)

Dominic Bégin, President & Managing Director

Senior Officer in previous versions
- Michael Casia, President & Managing Director

Government Funding

Did Organon Canada Inc. / Organon Canada inc. receive government funding within the last 12 months? No

Other Entities (working together for the purposes of lobbying) Information

Organon Canada Inc. / Organon Canada inc. is not working together with any other entity for the purpose of lobbying.

Direct Interests of the Lobbying Activity

Affiliates

Organon Canada Inc. / Organon Canada inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Organon & Co., Inc. (Address information)

Other Affiliates

The activities of Organon Canada Inc. / Organon Canada inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Organon Canada Inc. / Organon Canada inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Organon Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including biosimilar drugs and women’s health products, which are the company’s main sectors of activities.	Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Promote the development of a Pan Canadian health strategy, including the creation policies addressing biosimilars and the implementation of a national pharmacare program.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
To actively promote the value of the pharmaceutical industry for British Columbia's economic health and well being, but more importantly for the health and well being of its citizens and to propose solutions for integrated health care in British Columbia. As part of the initiatives, Organon Canada Inc. seeks to have its products listed on the relevant BC PharmaCare program formulary and enhance publicly funded women’s health initiatives/programs.	Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
To contribute to British Columbia’s economic prosperity by recommending policies that will attract increased investment. Activities could include providing recommendations on tax policies, research programs and policies, as well as policies and programs regarding innovation. Focus of lobbying efforts is on representations relating to the conditions under which biosimilar drugs are marketed and reimbursed in British Columbia, including under the BC PharmaCare programs. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current women’s health programs, the integration of biosimilar drugs into the BC PharmaCare programs.	Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Fraser Health Authority
Health
Interior Health Authority
Member(s) of the BC Legislative Assembly
Northern Health Authority
Provincial Health Services Authority
University of British Columbia
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Raman Bhullar
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No